Vaxart, Inc.
VXRT
$0.58
$0.022.70%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 37.10M | 16.33M | -50.70M | -56.64M | -58.12M |
| Total Depreciation and Amortization | 7.46M | 8.58M | 8.76M | 8.90M | 8.92M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.67M | 5.37M | 7.10M | 7.29M | 8.56M |
| Change in Net Operating Assets | -35.96M | -22.56M | 4.55M | 3.36M | 7.47M |
| Cash from Operations | 15.26M | 7.71M | -30.29M | -37.09M | -33.17M |
| Capital Expenditure | -463.00K | -145.00K | -188.00K | -80.00K | -553.00K |
| Sale of Property, Plant, and Equipment | 8.00K | 5.00K | 5.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.18M | 16.77M | 25.23M | 13.91M | -2.52M |
| Cash from Investing | 2.72M | 16.63M | 25.05M | 13.83M | -3.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.62M | 4.62M | 3.04M | 3.04M | 41.16M |
| Repurchase of Common Stock | -370.00K | -199.00K | -184.00K | -190.00K | -200.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -184.00K | -184.00K | -2.76M | -2.76M | -2.76M |
| Cash from Financing | 4.07M | 4.24M | 93.00K | 87.00K | 38.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.05M | 28.59M | -5.16M | -23.17M | 1.96M |